Ghost Tree Capital, LLC Exelixis, Inc. Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $6.35 Million - $8.96 Million	-400,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $7.42 Million - $8.98 Million	400,000 New	400,000 $8.61 Million
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $1.3 Million - $1.65 Million	-53,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $1.25 Million - $1.56 Million	53,500	53,500 $1.3 Million

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.